Laura Lee Sandler, Chief Operating Officer at Oruka Therapeutics, Inc. (ORKA), sold 600 shares at $69.69 ($42K) on 2026-06-15, disclosed to the SEC on 2026-06-15.
Open-market sale of $42k ORKA by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORKA | SELL | 2026-05-01 | $319K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $25K | — | Filing → |
| ORKA | SELL | 2026-03-02 | $168K | — | Filing → |